You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
远大医药(00512.HK)新产品於比利时获批开展与COVID-19相关IIa期临床研究
阿思达克 04-19 17:54
远大医药(00512.HK)公布,附属Grand Medical Pty Ltd正在开发,用於重症感染领域的全球创新药物STC3141,日前已获得批准在比利时开展用於治疗2019冠状病毒病的IIa期临床研究。

公告指,此次STC3141获批在比利时开展治疗COVID-19的IIa期临床研究,将在至少三个研究中心入组25名患者开展随机开放式单臂研究,旨在研究和评估药物在治疗因感染COVID-19 所引发的病毒性肺炎重症患者中的安全性和有效性,进一步扩大产品的适用范围,积累更多资料综合评估後期临床试验的风险和获益,以加快产品的全球开发进程。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account